Northern Light Venture Capital logo

Northern Light Venture Capital

Asia, Beijing, China, Beijing

Description

Northern Light Venture Capital (NLVC) is a prominent venture capital firm based in Beijing, China, established in 2005. The firm has carved out a significant niche in the Chinese venture landscape, primarily focusing on early- and growth-stage investments across a diverse range of sectors. NLVC targets companies in technology, media, telecommunications (TMT), consumer services, healthcare, and advanced technologies, demonstrating a broad yet strategic investment mandate aimed at disruptive innovations and market leaders.

NLVC's investment philosophy emphasizes identifying and nurturing companies with strong management teams, innovative business models, and significant market potential. Over its nearly two-decade history, the firm has built an impressive portfolio, including several high-profile successes and unicorns. Notable investments include early backing of giants like Meituan-Dianping and ByteDance, which have grown to become dominant forces in their respective industries. Their strategic support often extends beyond capital, providing operational guidance and industry connections to their portfolio companies.

The firm manages multiple funds, with substantial capital under management. For instance, NLVC successfully closed its sixth USD fund at $1.2 billion and a new RMB fund at 3.5 billion yuan in 2021, underscoring its robust financial capacity and continued commitment to the Chinese market. These significant fund sizes enable NLVC to deploy substantial capital, with typical first check sizes ranging from approximately $5 million for promising early-stage ventures to potentially $40 million or more for growth-stage companies requiring larger capital injections. This flexibility allows them to engage with companies across various stages of development, from Series A to later growth rounds.

NLVC's consistent track record of identifying and scaling successful enterprises has solidified its reputation as a leading venture capital player in China. Its deep understanding of the local market dynamics, combined with a global perspective, positions it as a preferred partner for ambitious entrepreneurs seeking to revolutionize their industries.

Investor Profile

Northern Light Venture Capital has backed more than 109 startups, with 3 new investments in the last 12 months alone. The firm has led 23 rounds, about 21% of its total and boasts 51 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, Singapore.
  • Strong thematic focus on Software, Information Technology, Internet.
  • Led 2 rounds in the past year.
  • Typical check size: $5M – $40M.

Stage Focus

  • Series A (25%)
  • Series B (23%)
  • Series C (20%)
  • Series D (11%)
  • Seed (10%)
  • Series Unknown (6%)
  • Post Ipo Equity (2%)
  • Angel (2%)
  • Series E (1%)

Country Focus

  • China (55%)
  • United States (36%)
  • Singapore (5%)
  • South Korea (3%)
  • South Africa (2%)

Industry Focus

  • Software
  • Information Technology
  • Internet
  • Manufacturing
  • Mobile
  • Health Care
  • Semiconductor
  • E-commerce
  • Biotechnology
  • Security
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Northern Light Venture Capital frequently co-invest with?

Qualcomm Ventures
North America, California, United States, San Diego
Co-Investments: 8
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 17
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 9
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 15
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 5
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 11
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 13
Oriza Ventures
North America, California, United States, Santa Clara
Co-Investments: 7
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 7
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 6

Which angels does Northern Light Venture Capital often collaborate with?

CS
North America, California, United States, San Francisco
Shared Deals: 1
MS
Europe, England, United Kingdom, London
Shared Deals: 1
Shawn Shi
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
MN
North America, California, United States, San Mateo
Shared Deals: 1
CB
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
OD
North America, New York, United States, New York
Shared Deals: 1
RC
North America, California, United States, San Francisco
Shared Deals: 1
NC
North America, United States
Shared Deals: 1

What are some of recent deals done by Northern Light Venture Capital?

Bianzhong New Materials

Shenzhen, Guangdong, China

Bianzhong New Materials specializes in the research and development of equipment for weaving and shaping three-dimensional preforms.

Advanced Materials
SeedJan 20, 2026

SuperMagnetic New Energy focused on the development of high-temperature superconducting high-field magnets

AngelJan 16, 2026
Vibrant

Guangzhou, Guangdong, China

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines.

Artificial Intelligence (AI)Health CareInformation Technology
Series UnknownJan 12, 2026
Amount Raised: $61,000,000
Spiro Medical

Menlo Park, California, United States

Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.

BiotechnologyClinical TrialsMedicalMedical Device
Series AJan 7, 2026
Amount Raised: $67,000,000
BV Laser

Nanjing, Jiangsu, China

BV Laser is a manufacturer of medical beauty equipment.

LaserManufacturingMedical DeviceProduct Design
Series CDec 15, 2025
Amount Raised: $14,182,989
Sanegene Bio

Woburn, Massachusetts, United States

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

BiopharmaHealth CareMedicalTherapeutics
Series BDec 8, 2025
Amount Raised: $110,000,000
Kind Pharmaceutical

Hangzhou, Zhejiang, China

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.

BiopharmaBiotechnologyHealth CareTherapeutics
Series CNov 12, 2025
Amount Raised: $56,207,405
HiDiamond Biotechnology

Suzhou, Jiangsu, China

HiDiamond Biotechnology is a biopharmaceutical company offering research and development for therapeutic products and molecular entities.

BiopharmaBiotechnologyLife Science
SeedSep 17, 2025
Amount Raised: $14,068,259
iRegene

Wuhan, Hubei, China

iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.

Health CareMedicalTherapeutics
Series BSep 4, 2025
Hertz Life Science Technology

Shenzhen, Guangdong, China

Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.

BiopharmaBiotechnologyHealth Care
Series UnknownSep 1, 2025

Find More Investors Like Northern Light Venture Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Northern Light Venture Capital | Pipeseed